Head and neck cancers of unknown primary: A diagnostic and therapeutic challenge

1. Martin H. Untimely lymph node biopsy. Am J Surg. 1961;102(1):17-18. DOI: 10.1016/0002-9610(61)90679-1. Open DOISearch in Google Scholar

2. Civantos FJ, Vermorken JB, Shah JP, Rinaldo A, Suarez C, Kowalski LP, et al. Metastatic squamous cell carcinoma to the cervical lymph nodes from an unknown primary cancer: management in the HPV era. Front Oncol. 2020;10:593164. DOI: 10.3389/fonc.2020.593164. Open DOISearch in Google Scholar

3. Pavlidis N, Briasoulis E, Hainsworth J, Greco F. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer. 2003;39(14):1990-2005. Search in Google Scholar

4. Guntinas-Lichius O, Klussman J, Dinh S, Dinh M, Schmidt M, Semrau R, et al. Diagnostic work-up and outcome of cervical metastases from an unknown primary. Acta Otolaryngol. 2006;126(5):536-44. Search in Google Scholar

5. Jereczek-Fossa BA, Jassem J, Orecchia R. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Rev. 2004;30(2):153-64. DOI: 10.1016/j.ctrv.2003.10.001. Open DOISearch in Google Scholar

6. Chernock RD, Lewis JS. Approach to metastatic carcinoma of unknown primary in the head and neck: squamous cell carcinoma and beyond. Head Neck Pathol. 2015;9(1):6-15. DOI: 10.1007/s12105-015-0616-2. Open DOISearch in Google Scholar

7. Cianchetti M, Mancuso AA, Amdur RJ, Werning JW, Kirwan J, Morris CG, et al. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope. 2009;119(12):2348-54. DOI: 10.1002/lary.20638. Open DOISearch in Google Scholar

8. Schroeder L, Boscolo-Rizzo P, Cin ED, Romeo S, Baboci L, Dyckhoff G, et al. Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre study. Eur J Cancer. 2017;74:73-81. DOI: 10.1016/j.ejca.2016.12.020. Open DOISearch in Google Scholar

9. Balk M, Rupp R, Mantsopoulos K, Sievert M, Gostian M, Allner M, et al. Factors influencing the outcome of head and neck cancer of unknown primary (HNCUP). J Clin Med. 2022;11(10):2689. DOI: 10.3390/jcm11102689. Open DOISearch in Google Scholar

10. Kennel T, Garrel R, Costes V, Boisselier P, Crampette L, Favier V. Head and neck carcinoma of unknown primary. Eur Ann Otorhinolaryngol Head Neck Dis. 2019;136(3):185-92. DOI: 10.1016/j.anorl.2019.04.002. Open DOISearch in Google Scholar

11. Issing WJ, Taleban B, Tauber S. Diagnosis and management of carcinoma of unknown primary in the head and neck. Eur Arch Otorhinolaryngol. 2003;260(8):436-43. DOI: 10.1007/s00405-003-0585-z. Open DOISearch in Google Scholar

12. Robbins KT, Clayman G, Levine PA, Medina J, Sessions R, Shaha A, et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology- Head and Neck Surgery. Arch Otolaryngol Head Neck Surg. 2002;128(7):751-8. DOI: 10.1001/archotol.128.7.751. Open DOISearch in Google Scholar

13. Neagu A. Diagnosticul si tratamentul tumefactiilor cervicale. In: Popescu I, Ciuce C (red.), Sarafoleanu C (coord.). Tratat de chirurgie. Vol. 1: Otorinolaringologie si chirurgie cervico-faciala. Editura Academiei Romana, Bucuresti; 2012, p. 383-425. Search in Google Scholar

14. Weiss D, Koopman M, Rudack C. Prevalence and impact on clinicopatho-logical characteristics of human papillomavirus-16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma. Head Neck. 2011;33(6):856-62. Search in Google Scholar

15. Oren N, Vaysberg A, Ginat DT. Updated WHO nomenclature of head and neck lesions and associated imaging findings. Insights Imaging. 2019;10(1):72. DOI: 10.1186/s13244-019-0760-4. Open DOISearch in Google Scholar

16. Deschler DG, Richmon JD, Khariwala SS, Ferris RL, Wand MB. The “new” head and neck cancer patient – young, nonsmoker, nondrinker, and HPV positive: Evaluation. Otolaryngol Head Neck Surg. 2014;151(3):375-80. DOI: 10.1177/0194599814538605. Open DOISearch in Google Scholar

17. Kalavacherla S, Sanghvi P, Lin GY, Guo T. Updates in the management of unknown primary of the head and neck. Front Oncol. 2022;12:991838. DOI: 10.3389/fonc.2022.991838. Open DOISearch in Google Scholar

18. Grani G, Fumarola A. Thyroglobulin in lymph node fine-needle aspiration washout: a systematic review and meta-analysis of diagnostic accuracy. J Clin Endocrinol Metab. 2014;99(6):1970-82. DOI: 10.1210/jc.2014-1098. Open DOISearch in Google Scholar

19. Karanikas G, Moameni A, Poetzi C, Zettinig G, Kaserer K, Bieglmayer C, et al. Frequency and relevance of elevated calcitonin levels in patients with neoplas-tic and nonneoplastic thyroid disease and in healthy subjects. J Clin Endocrinol Metab. 2004;89(2):515-9. DOI: 10.1210/jc.2003-030709. Open DOISearch in Google Scholar

20. Wong HH, Wang J. Merkel cell carcinoma. Arch Pathol Lab Med. 2010;134(11):1711-6. DOI: 10.5858/2009-0165-RSR2.1. Open DOISearch in Google Scholar

21. Trosman S, Chute D, Wood B, Lamarre E. Unknown primary mucoepidermoid carcinoma: diagnosis and treatment. Head Neck. 2015;37(2):E22-5. DOI: 10.1002/hed.23766. Open DOISearch in Google Scholar

22. López F, Rodrigo JP, Silver CE, Haigentz M, Bishop JA, Strojan P, et al. Cervical lymph node metastases from remote primary tumor sites. Head Neck. 2016;38(Suppl 1):E2374-85. DOI: 10.1002/hed.24344. Open DOISearch in Google Scholar

23. Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB. Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radio-ther Oncol. 2000;55(2):121-9. DOI: 10.1016/s0167-8140(00)00172-9. Open DOISearch in Google Scholar

24. Maghami E, Ismaila N, Alvarez A, Chernock R, Duwuri U, Geiger J, et al. Diagnosis and management of squamous cell carcinoma of unknown primary in the head and neck: ASCO Guideline. J Clin Oncol. 2020;38:2570-96. Search in Google Scholar

25. Di Maio P, Iocca O, De Virgilio A, Giudice M, Pellini R, D’Ascanio L, et al. Narrow band imaging in head and neck unknown primary carcinoma: A systematic review and meta-analysis. Laryngoscope. 2020;130(7):1692-1700. DOI: 10.1002/lary.28350. Open DOISearch in Google Scholar

26. Shinozaki T, Hayashi R, Ebihara M, Miyazaki M, Daiko H, Saikawa M, et al. Narrow band imaging endoscopy for unknown primary tumor sites of the neck. Head Neck. 2012;34(6):826-9. DOI: 10.1002/hed.21825. Open DOISearch in Google Scholar

27. Monnet O, Cohen F, Lecorroller T, Vidal V, Jacquier A, Gaubert JY, et al. Cervical lymph nodes. J Radiol. 2008;89(7-8 Pt 2):1020-36. DOI: 10.1016/s0221-0363(08)73905-2. Open DOISearch in Google Scholar

28. Ye W, Arnaud EH, Langerman A, Mannion K, Topf MC. Diagnostic approaches to carcinoma of unknown primary of the head and neck. Eur J Cancer Care (Engl). 2021;30(6):e13459. DOI: 10.1111/ecc.13459. Open DOISearch in Google Scholar

29. Sokoya M, Chowdhury F, Kadakia S, Ducic Y. Combination of panendoscopy and positron emission tomography/computed tomography increases detection of unknown primary head and neck carcinoma. Laryngoscope. 2018;128(11):2573-5. DOI: 10.1002/lary.27268. Open DOISearch in Google Scholar

30. Han A, Xue J, Hu M, Zheng J, Wang X. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary. Cancer Epidemiol. 2012;36(5):470-5. DOI: 10.1016/j.canep.2012.03.002. Open DOISearch in Google Scholar

31. Deonarine P, Han S, Poon FW, de Wet C. The role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the management of patients with carcinoma of unknown primary. Scott Med J. 2013;58(3):154-62. DOI: 10.1177/0036933013496958. Open DOISearch in Google Scholar

32. Tandon S, Shahab R, Benton JI, Ghosh SK, Sheard J, Jones TM. Fine-needle aspiration cytology in a regional head and neck cancer center: comparison with a systematic review and meta-analysis. Head Neck. 2008;30(9):1246-52. DOI: 10.1002/hed.20849. Open DOISearch in Google Scholar

33. Ferreira VHC, Sassi LM, Zanicotti RTS, Ramos GHA, Jung JE, Schussel JL. Core needle biopsy in the diagnosis of head and neck lesions: a retrospective study of 3 years. Eur Arch Otorhinolaryngol. 2016;273(12):4469-72. DOI: 10.1007/s00405-016-4139-6. Open DOISearch in Google Scholar

34. Lydiatt WM, Patel SG, O’Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, et al. Head and neck cancers – major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):122-37. DOI: 10.3322/caac.21389. Open DOISearch in Google Scholar

35. American Joint Committee on Cancer. AJCC Cancer Staging Form Suppliment. AJCC Cancer Staging Manual, Eighth Edition. [Internet]. [updated Jun 5, 2018]. Available from: file:///C:/Users/enach/OneDrive/Desktop/Head%20neck%20cancer%20unknown%20primary/AJCC%20Cancer%20 Staging%20Form%20Supplement%20to%20the%20AJCC%20Cancer%20 Staging%20Manual,%20Eighth%20Edition%20(%20PDFDrive%20).pdf. Search in Google Scholar

36. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Head and neck cancers. NCCN evidence blocksᵀᴹ. Version 2.2022. Available from: file:///C:/Users/enach/OneDrive/Desktop/Head%20neck%20cancer%20unknown%20primary/head-and-neck_blocks.pdf. Accessed November 28, 2022. Search in Google Scholar

37. Begum S, Gillison ML, Nicol TL, Westra WH. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res. 2007;13(4):1186-91. DOI: 10.1158/1078-0432.CCR-06-1690. Open DOISearch in Google Scholar

38. Svajdler M Jr., Kaspirkova J, Hadravsky L, Laco J, Dubinsky P, Straka L, et al. Origin of cystic squamous cell carcinoma metastases in head and neck lymph nodes: Addition of EBV testing improves diagnostic accuracy. Pathol Res Pract. 2016;212(6):524-31. DOI: 10.1016/j.prp.2016.03.002. Open DOISearch in Google Scholar

39. Frank SJ, Rosenthal DI, Petsuksiri J, Ang KK, Morrison WH, Weber RS, et al. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure. Int J Radiat Oncol Biol Phys. 2010;78(4):1005-10. DOI: 10.1016/j.ijrobp.2009.09.006. Open DOISearch in Google Scholar

40. Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, et al. Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2012;84(5):1198-205. DOI: 10.1016/j.ijrobp.2012.05.008. Open DOISearch in Google Scholar

41. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24-35. DOI: 10.1056/NEJMoa0912217. Open DOISearch in Google Scholar

42. Bourhis J, Sire C, Graff P, Gregoire V, Maingon P, Calais G, et al. Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. Lancet Oncol. 2012;13(2):145-53. DOI: 10.1016/S1470-2045(11)70346-1. Open DOISearch in Google Scholar

43. Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemo-therapy in advanced-stage oropharynx carcinoma. J Clin Oncol. 2004;22(1):69-76. DOI: 10.1200/JCO.2004.08.021. Open DOISearch in Google Scholar

44. Adelstein DJ, Moon J, Hanna E, Giri PGS, Mills GM, Wolf GT, et al. Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216). Head Neck. 2010;32(2):221-8. DOI: 10.1002/hed.21179. Open DOISearch in Google Scholar

45. Zhang Y, Chen L, Hu GQ, Zhang N, Zhu XD, Yang KY, et al. Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma. N Engl J Med. 2019;381:1124-35. DOI: 10.1056/NEJMoa1905287. Open DOISearch in Google Scholar

46. Axelsson L, Nyman J, Haugen-Cange H, Bove M, Johansson L, De Lara S, et al. Prognostic factors for head and neck cancer of unknown primary including the impact of human papilloma virus infection. J Otolaryngol Head Neck Surg. 2017;46(1):45. DOI: 10.1186/s40463-017-0223-1. Open DOISearch in Google Scholar

47. Sivars L, Tani E, Nasman A, Ramqvist T, Munck-Wikland E, Dalianis T. Human Papillomavirus as a diagnostic and prognostic tool in cancer of unknown primary in the head and neck region. Anticancer Res. 2016;36(2):487-93. Search in Google Scholar

48. Cheraghlou S, Torabi SJ, Husain ZA, Otremba MD, Osborn HA, Mehra S, et al. HPV status in unknown primary head and neck cancer: prognosis and treatment outcomes. Laryngoscope. 2019;129(3):684-91. DOI: 10.1002/lary.27475. Open DOISearch in Google Scholar